Government of Haryana

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Godrej Industries (NSE: GODREJIND) maps Rs 20,000cr Haryana investment

Godrej Industries Group has signed an MoU for around ₹20,000 crore of future Haryana investment, with Godrej Properties accounting for ₹16,000 crore and Godrej Ventures another ₹3,500 crore.

byPallavi Madhiraju

August 27, 2026

Representative image: EV chargers, solar panels and battery storage systems inside a clean energy manufacturing facility, reflecting Servotech Renewable’s ₹400 crore Haryana MoU and India’s expanding EV charging and renewable power electronics supply chain.

Is Servotech Renewable building the next leg of India’s EV charging and storage supply chain?

Find out how Servotech Renewable’s ₹400 crore Haryana MoU could reshape its EV charger, battery storage and clean energy growth strategy.

byPallavi Madhiraju

June 4, 2026

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Godrej Industries (NSE: GODREJIND) maps Rs 20,000cr Haryana investment

Is Servotech Renewable building the next leg of India’s EV charging and storage supply chain?

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

SAMILBIO expands Chaeyun skincare with two November launches as K-beauty exports reach $11.1bn

Schneider Electric Infrastructure (SCHNEIDER) shares fall 3.5% despite new factory expansion: What will November results reveal?

Haleon (HLN) near 319p: Does a 15% share-price crash make its valuation attractive after the growth downgrade?

Ethan Allen will split CEO and chair roles, but who gets to choose Farooq Kathwari’s successor?